New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 15, 2012
05:13 EDTDECK, ZNGA, AMRC, ZIP, BAC, HD, DNDN, GLD, WFMI, LOW, EXC, SBUX, CL, SIRI, PM, NLY, AGNC, CMI, PCAR, REGN, PFE, KO, MSFT, YHOO, AAPL, IBM, PCYC, JPM, MNST, HSTM, CONN, SXCI, QCOR, IDIX, VVUS, MDVN, PCLN, GS, ACATJim Cramer's "Mad Money"
Wednesday was Jim Cramer's anniversary of his "Mad Money" TV show. He said it's time to come off the sidelines, sell those bank CDs earning 0.4% interest and invest in great American companies. Cramer said today's markets are being driven by pure growth, U.S. growth. He said everything from health care to retail to technology, even the homebuilders, are just beginning to show sustainable recoveries. Stocks like JPMorgan Chase (JPM) and IBM (IBM), are both leading the charge. Then there's Apple (AAPL) Cramer said while some investors can't fathom Apple's historic rise, he remembers a time when Coca-Cola (KO) and Pfizer (PFE) were the most valued companies on Wall Street. Apple is so much more than just a technology company, he said, adding it's a communications, education and entertainment company as well, all of which makes it worth its valuation. Cramers said the markets can most certainly take out its recent highs and march into bull-market mode, with a pickup in commercial construction and improved job growth looming just around the corner. Cramer recapped his "Magnificent Seven" speculative stocks to show viewers just how lucrative this under-rated method of investing can be. He said that every investor should have one spot in their portfolio dedicated to a speculative stock that adds excitement to their holdings. Cramer's magnificent seven stocks included Pharmacyclics (PCYC), a stock up 393% over the past 12 months, Medivation (MDVN), a biotech up 320%, Idenix Pharmaceuticals (IDIX), up 277%, and Vivus (VVUS), up 224%. Rounding out the seven were Arctic Cat (ACAT), which has risen 204% in 12 months, Conn's (CONN), up 211% and HealthStream (HSTM), which is up 192%. Next, Cramer also highlighted the seven best stocks that he's recommended since "Mad Money" first aired back in 2005, a list that exemplifies what "staying in the game" is all about. His top seven recommendations included Monster Beverage (MNST), which has risen 1,600% over the past seven years, the biotech company Regeneron (REGN), up 1,700% over seven years and Medivation (MDVN), the only company to make both of Cramer's lists, up 1,800%. The list also included Green Mountain Coffee Roasters (GMCR), a stock that despite huge losses recently, is still up 2,700% over seven years, SXC Health Solutions (SXCI) up 2800%, travel site Priceline.com (PCLN), up 2,850% and finally, Questcor Pharmceuticals (QCOR), which has rallied an astounding 7,066% over seven years. Cramer said when companies are riding long-term trends, their successes can turn into huge gains for shareholders. Next, Cramer responded to a New York Times op-ed piece chastising Goldman Sachs (GS), saying that the company often put its own interests ahead of those of its clients. Cramer said he didn't see any of this type of behavior when he worked for Goldman years ago. He said while he's sure that many of Goldman's employees are still committed to doing right by clients, perhaps this article can serve as a wake-up call for the firm to do even better for its clients, even if that means being less profitable in the short term. MAD TWEETS: Cramer said that Microsoft (MSFT) was a good stock, Yahoo (YHOO) was a bad one and Sirius XM Radio (SIRI) was a speculative one. Deckers Outdoor (DECK), said the warm winter hit this cold-weather shoemaker hard. Cramer was bullish on Starbucks (SBUX). Restructuring is working at Lowes (LOW) but he still prefers Home Depot (HD), and with gold stocks still suffering, he still likes the SPDR Gold Shares (GLD). Finally when asked about ZipCar (ZIP), Cramer said if investors want to invest in a recent IPO, he'd go with mobile game maker Zynga (ZNGA). LIGHTNING ROUND: (Bullish) ECL;PM; PCAR; CMI; AGNC; NLY; AMRC; EXC; WFMI. (Bearish) DNDN; BAC. Reference Link
News For DECK;SIRI;NLY;AGNC;YHOO;MSFT;CMI;GS;PCLN;PCAR;QCOR;SXCI;PM;REGN;MNST;CL;HSTM;CONN;ZNGA;ACAT;IDIX;ZIP;VVUS;MDVN;BAC;HD;JPM;PCYC;DNDN;PFE;KO;GLD;WFMI;AAPL;IBM;LOW;EXC;SBUX;AMRC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | all recent news | >>
October 17, 2014
09:06 EDTJPMJPMorgan and PNC Financial weakness a buying opportunity, say Morgan Stanley
Subscribe for More Information
09:06 EDTREGNAmgen files patent infringement lawsuit against Sanofi, Regeneron
Amgen (AMGN) announced that it filed a lawsuit in the United States District Court of Delaware against Sanofi (SNY), Aventisub, formerly doing business as Aventis Pharmaceuticals, and Regeneron Pharmaceuticals (REGN) for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which are owned by Amgen, describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9, or PCSK9. By its complaint, Amgen seeks an injunction to prevent the infringing manufacture, use and sale of Sanofi and Regeneron's alirocumab, a monoclonal antibody targeting PCSK9. Sanofi and Regeneron recently announced that they have completed Phase 3 clinical trials on alirocumab and intend to pursue regulatory approval to market alirocumab in the U.S. Amgen previously announced submission of a Biologics License Application to the FDA for evolocumab, its own investigational human monoclonal antibody to PCSK9, for the treatment of high cholesterol, on Aug. 28.
08:57 EDTPCYCPharmacyclics price target raised to $188 from $185 at Roth Capital
Subscribe for More Information
08:51 EDTPCYCPharmacyclics announces European approval for Imbruvica
Subscribe for More Information
08:34 EDTPCYCPharmacyclics management to meet with JPMorgan
Subscribe for More Information
07:53 EDTAAPLFBI Director urges Apple, Google to change course on encryption, WSJ says
FBI Director James Comey, making his most extensive statements to date on encrypted phones and operating systems in a speech at the Brookings Institution, urged Apple (AAPL) and Google (GOOG) to take a step back, to pause to consider, I hope, a change of course, and called on lawmakers to update federal rules on how the government can intercept and monitor communication, reported The Wall Street Journal. Reference Link
07:33 EDTIBMIBM reinstated with a Neutral at BofA/Merrill
Target $200.
07:19 EDTAAPLApple 'extremely well' positioned into holiday season, says Cantor
Subscribe for More Information
07:07 EDTREGNRegeneron announces EYLEA results from NIH study
Subscribe for More Information
07:00 EDTJPMJPMorgan in talks to build corporate campus in Manhattan, NY Times reports
JPMorgan Chase (JPM) is in negotiations with New York state and city officials over a potential $6.5B deal that would result in the construction of a corporate campus with two high rises on the West Side of Manhattan, the Wall Street Journal reports. Reference Link
06:37 EDTACATArctic Cat initiated with a Hold at Wunderlich
Subscribe for More Information
06:34 EDTAAPLApple iPad refresh in-line with expectations, says Deutsche Bank
Subscribe for More Information
06:30 EDTMSFTNPD: Sony PlayStation4 outsells XBox One in September, GameSpot reports
Subscribe for More Information
06:26 EDTMSFTSony says PS4 September's top-selling console
Subscribe for More Information
06:24 EDTAAPLGlobal notebook shipments estimated at over 45M units, Digitimes Research says
Subscribe for More Information
06:16 EDTEXCExelon upgraded to Neutral from Sell at Citigroup
Subscribe for More Information
06:14 EDTAAPLApple debuts iPhone 6 in China, WSJ reports
Subscribe for More Information
06:13 EDTAAPLLVMH could pair with a tech company to launch smartwatch, WSJ reports
LVMH Moet Hennessy Louis Vuitton (LVMUY) says it could team up with with a technology company to launch a smartwatch for one of its brands, the Wall Street Journal reports. Jean-Claude Biver, president of LVMHs watch division, commented "Maybe in nine months, we will have a smartwatch." Publicly traded smartwatch makers include Apple (AAPL), Google (GOOG) and Samsung (SSNLF). Reference Link
05:57 EDTGLDSPDR Gold Trust overall implied volatility at 17; 26-week average is 15
Subscribe for More Information
05:35 EDTGSGoldman Sachs upgraded to Outperform from Market Perform at Keefe Bruyette
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use